Aureus Pharma Extends its Knowledge Database Agreement with Sanofi-Aventis R&D
News Nov 06, 2009
Aureus Pharma has announces the extension of its knowledge database agreement with sanofi-aventis research & development for an additional three-year term.
Under the agreement, Aureus will provide new AurSCOPE® knowledge databases and continue to update existing databases for sanofi-aventis' R&D division. The Aureus Pharma databases will give sanofi-aventis researchers access to information on major therapeutic targets. These include GPCR protein receptors, nuclear receptors, kinase inhibitors, ion channels, as well as information relative to drug safety including data on ADME (absorption, distribution, metabolism, and excretion).
The new agreement reinforces the relationship between Aureus Pharma and sanofi-aventis, which has been in existence for seven years already. It also secures additional revenues for Aureus over the next three years.
"Sanofi-aventis' decision to extend the partnership for an additional three year period, as well as to acquire new knowledge bases, confirms the fact that Aureus' products are meeting the needs of the world's leading pharmaceutical companies," said Dr Jason Theodosiou, CEO of Aureus Pharma.
Aureus Pharma's information solutions are working for many of the world's most successful biopharmaceutical companies and prestigious research institutions.
Sanchi Oil Spill Contamination Could Take Three Months to Reach MainlandNews
Water contaminated by the oil currently leaking into the ocean from the Sanchi tanker collision is likely to take at least three months to reach land, and if it does the Korean coast is the most likely location. However, the oil’s fate is highly uncertain, as it may burn, evaporate, or mix into the surface ocean and contaminate the environment for an extended duration.READ MORE
Concept Life Sciences appoints New Group Programme Manager and US Head of SalesNews
Key leadership appointments support integration of the Group and expansion in the US market.READ MORE